Early Access — free while we kick the tires
EdgarHawk

Parker Stuart B.

Director

Director
3 filings analyzed · 2 companies · Latest 2025-11-12

Companies

Company Buys Sells Direction
KEMPER Corp KMPR 1 1 Neutral
HEALTHEQUITY, INC. HQY 0 2 Net selling

Activity

November 2025
2025-11-12 KEMPER Corp KMPR
high
Buy
25,000 shares
$920,500
Significance 6/10

Director Parker Stuart B. purchases 25,000 shares of KMPR at $36.82; doubles holdings to 48,152 shares as stock down 48.9% from 52-week high.

Director Parker Stuart B. executed a substantial open-market purchase of 25,000 shares at $36.82, effectively doubling his stake from 23,152 to 48,152 shares totaling $920,500. This transaction occurs against a backdrop of significant price deterioration: KMPR has fallen 48.9% from its 52-week high of $72.10 and declined 23.4% over the prior 30 days and 31.9% over 90 days. Notably, the director's prior purchase at this ticker on 2023-11-20 produced a +44.8% 90-day return, establishing a historical precedent for favorable outcomes from his KMPR buys. However, the company faces headwinds with net income of $-21.0M against revenue of $1,239,700,000.00, annual revenue declining 6.2% year-over-year, and a low P/E of 8.67 suggesting distressed valuation conditions. The timing and scale of this doubled position merit monitoring given the concurrent operational challenges and stock momentum.

December 2024
2024-12-13 HEALTHEQUITY, INC. HQY
medium
Sell
25,000 shares
$2,417,900
Significance 5/10

Director Parker Stuart B. sells 25,000 HQY shares (25.0K shares) for $2,417,900.17 in 2 transactions at $96.70–$97.30.

Director Parker Stuart B. executed 2 separate sales totaling 25,000 shares (25.0K shares) for $2,417,900.17 on 2024-12-12, reducing his holdings from 44,061 shares (44.1K shares) to 19,061 shares (19.1K shares)—a -56.7% reduction in his stake. The blended average transaction price of $96.72 sits within the 52-week range of $62.44–$104.65 and is currently 1.1% above the current price of $95.62. His cross-ticker track record shows 1 prior sell with an average 90-day return of +0.6% and a well-timed rate of 0.00%, indicating past sales were not well-timed (stock generally rose post-sale). The company's fundamentals show strong annual revenue growth of +16.0% and a quarterly revenue base of $300,432,000.00 ($300.4M), though the P/E ratio of 85.38 reflects elevated valuation relative to the net income of $5,703,000.00 ($5.7M). The substantial reduction in holdings warrants examination into whether this reflects a liquidity need, portfolio rebalancing, or a change in the insider's position outlook.

August 2024
2024-08-23 KEMPER Corp KMPR
medium
Sell
30,000 shares
$1,852,200
Significance 4/10

Director Parker Stuart B. sold 30,000 shares of KMPR at $61.74 (Aug 21), reducing stake by 59.2% to 20,717 shares.

Parker Stuart B. executed a substantial open-market sale of 30,000 shares ($1.9M) on 2024-08-21, cutting his KEMPER holdings from 50,717 to 20,717 shares—a 59.2% reduction. The sale occurred at $61.74, just 0.6% below the current price of $62.11 and within 1.5% of the 52-week high of $65.76, suggesting opportunistic execution near recent peaks. The company faces structural headwinds: annual revenue declined 11.3% year-over-year, the firm was unprofitable over its most recent full fiscal year despite $1.1B in quarterly revenue, and the P/E of 77.64 reflects depressed near-term earnings power. His cross-ticker track record shows a 100% win rate with an average 90-day return of +44.8%, though his single prior KMPR purchase (Nov 2023) has returned only +14.1% and +44.8% at 30 and 90 days respectively—modest outperformance relative to his broader pattern.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access